ContraFect to Present CF-301 Data at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
ContraFect Corporation (CFRX)
Last contrafect corporation earnings: 3/18 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.contrafect.com
Company Research
Source: GlobeNewswire
YONKERS, N.Y., April 11, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announced the presentation of data on its lead drug candidate CF-301 at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) to be held from April 21-24, 2018, in Madrid, Spain. The presentations include results from in vitro, in vivo and microbiologic surveillance studies of ContraFect’s lead lysin CF-301, which is currently being evaluated in a Phase 2 clinical trial as a potential treatment for Staphylococcus aureus (Staph aureus) bacteremia, including endocarditis. Topics to be covered include CF-301’s synergy with standard of care antibiotics (SOC) including optimal timing of CF-301 administration relative to SOC and suppression of resistance to SOC; anti-biofilm activity against
Show less
Read more
Impact Snapshot
Event Time:
CFRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CFRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CFRX alerts
High impacting ContraFect Corporation news events
Weekly update
A roundup of the hottest topics